About Granata Bio
Granata Bio is a company based in Duxbury (United States) founded in 2018 by Marc Alain Chung, Sarah Faranda, Evan Sussman, and Dave Paller. Granata Bio has raised $29 million across 3 funding rounds from investors including Gedeon Richter, Vibe Bio and CooperSurgical. Granata Bio offers products and services including Biopharmaceuticals. Granata Bio operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, OvaScience and Rejoni, among others.
- Headquarter Duxbury, United States
- Founders Marc Alain Chung, Sarah Faranda, Evan Sussman, Dave Paller
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Granata Bio Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Gedeon Richter
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Granata Bio
Granata Bio offers a comprehensive portfolio of products and services, including Biopharmaceuticals.
Products for treating women's reproductive health issues.
People of Granata Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Granata Bio
Granata Bio has successfully raised a total of $29M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Granata Bio
Granata Bio has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Gedeon Richter, Vibe Bio and CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on women's health and sexual wellbeing.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Locked | Locked | Locked |
Investor details for Granata Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Granata Bio
Investment portfolio details for Granata Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Granata Bio
Detailed financials for Granata Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Granata Bio Comparisons
Peer comparison for Granata Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Granata Bio
Granata Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, OvaScience and Rejoni, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of new fertility treatments for women
|
|
| Locked | Locked | Locked |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
Detailed competitors of Granata Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Granata Bio
Complete news archive for Granata Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Granata Bio
Granata Bio was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Granata Bio is headquartered in Duxbury, United States. It is registered at Duxbury, Massachusetts, United States.
Evan Sussman is the current CEO of Granata Bio. They have also founded this company.
Granata Bio is a funded company, having raised a total of $29M across 3 funding rounds to date.
Granata Bio was founded in 2018 in Duxbury, United States, within the biotechnology sector. Therapeutics focused on womens health and infertility are developed through a pipeline that includes Ganirelix Acetate Injection for specific treatments, Milophene for ovulation induction, Progesterone for luteal phase support, and GB-hMG for infertility management. Operations center on advancing these drug candidates for clinical applications.
Granata Bio's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Granata Bio offers Biopharmaceuticals.
Granata Bio has 6 investors. Key investors include Gedeon Richter, Vibe Bio, CooperSurgical, Amboy Street Ventures, and Google Ventures.